1. United States
2. Idaho
3. Letter

The Healthy Technology Act of 2025 seeks to amend the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence (AI) and machine learning technologies to qualify as practitioners eligible to prescribe drugs. While advancements in AI could potentially improve healthcare accessibility and efficiency, there are valid concerns about relying solely on these technologies without proper human oversight and regulation. AI systems can perpetuate biases encoded in their training data and lack the nuanced judgment that human practitioners possess. A prudent approach would be to establish robust guidelines ensuring AI prescription tools meet rigorous safety and ethical standards, with medical professionals retaining ultimate decision-making authority over treatment plans. Responsible integration of AI should enhance rather than replace the patient-doctor relationship. I urge careful consideration of this complex issue to safeguard public health and ensure AI augments human expertise rather than replaces it entirely.